ACUTE PANCREATITIS PROF. DR. SALİH PEKMEZCİ
PATHOGENESIS pancreatic enzymes and activation of cascade systems Proelastase, Kimotrypsinogen, Prekallikrein, C3, Prophospholipase Plazminogen, Factor 12 trypsinogen Enterokinase and lisosomal katepsin
TRYPSİN Kininogen Elastase Kimotrypsin Phospholipase
Kallikrein C3a Plasmin Factor 12a
Kinin
MECHANISMS OF PANCREATITIS •OBSTRUCTION OF PANCREATIC DUCT •COMMON CHANNEL HYPOTHESIS •REFLUX OF ACTIVATED PANCREATIC ENZYMES •INCREASED DUCTAL PERMEABILITY •OTHERS
ETIOLOGY • • • • • • • • • • •
ALCOHOL GALLSTONES TRAUMA DUCTAL OBSTRUCTION INFECTION DRUGS METABOLIC DISTURBANCES ISCHEMIA HYPERPARATHYROIDISM IDIOPATIC OTHERS
ETIOLOGY • • • • • • • • • •
ALCOHOL GALLSTONE TRAUMA DUCTAL OBSTRUCTION INFECTION DRUGS METABOLIC DISTURBANCES ISCHEMIA OTHER IDIOPATIC
PATHOGENESIS OF ALCOHOL INDUCED PANCREATITIS • PARTIAL OBSTRUCTION IN AMPULLA • HYPERSECRETION OF PANCREAS • PROTEIN PLUGS IN PANCREATIC DUCT • PANCREATIC ISCHEMIA
THE PATHWAY OF ALCOHOL INDUCED PANCREATITIS BY ISCHEMIA ALCOHOL
PANCREATIC ISCHEMIA
XANTHINE DEHYDROGENASE
XANTHINE OXIDASE
metabolysme ACETALDEHYDE
FREE OXYGEN RAD
ETIOLOGY • ALCOHOL • GALLSTONE • TRAUMA • DUCTAL
OBSTRUCTION
• INFECTION • DRUGS • METABOLIC DISTURBANCES • ISCHEMIA • OTHER
RISK FACTORS IN BILIARY PANCREATITIS • MULTIPLE SMALL GALLSTONES IN GALLBLADDER • LARGE CYSTIC DUCT • CHOLEDOCOLITHIASIS • LARGE CHOLEDOC-WIRSUNG ANGLE • COMMON CHANNEL > 5 MM
ETIOLOGY • ALCOHOL • GALLSTONE • TRAUMA • DUCTAL
OBSTRUCTION
• INFECTION • DRUGS • METABOLIC DISTURBANCES • ISCHEMIA • OTHER
COMMON CHANNEL IS OBSERVED IN %90 OF PATİENTS WITH BILIARY PANCREATITIS, WHEREAS ONLY IN %20 OF PATIENTS WHO DID NOT PRESENT PANCREATITIS
ETIOLOGY • ALCOHOL • GALLSTONE • TRAUMA • DUCTAL
OBSTRUCTION
• INFECTION • DRUGS • METABOLIC DISTURBANCES • ISCHEMIA • OTHER
TRAUMA A- POSTOPERATIVE OR POSTERCP B- FOLLOWING BLUNT OR PENETRATING TRAUMA
ETIOLOGY • ALCOHOL • GALLSTONE • TRAUMA
ETIOLOGY IN
POSTOPERATIVE PANCREATITIS
• DUCTAL
OBSTRUCTION
• INFECTION • DRUGS • METABOLIC DISTURBANCES • ISCHEMIA • OTHER
• DIRECT TRAUMA • ISCHEMIA • MICROEMBOLI AND TROMBUS • DRUGS USED POSTOPERATIVELY (Azathioprine,steroids, calcium vs.)
ETIOLOGY • ALCOHOL • GALLSTONE • TRAUMA • DUCTAL
OBSTRUCTION
• INFECTION • DRUGS • METABOLIC DISTURBANCES • ISCHEMIA • OTHER
ETIOLOGY IN PANCREATITIS
POST-ERCP
• OVER MANIPULATION • DIATHERMIA • FORCED IRRIGATION OR CONTRAST AGENT INFUSION
ETIOLOGY • ALCOHOL • GALLSTONE • TRAUMA • DUCTAL
OBSTRUCTION
• INFECTION • DRUGS • METABOLIC DISTURBANCES • ISCHEMIA • OTHER
DUCTAL OBSTRUCTION • • • • •
PANCREATIC TUMORS DUCTAL STRICTURE PENETRATED DUODENAL ULCER AFFERENT LOOP SYNDROME ANATOMICAL OR PHYSIOLOGICAL ANOMALIES
ETIOLOGY
VIRAL Mumps, Coxsackie B, Enterovirus, EBV, CMV, Hepatitis B, Hepatitis A,
• ALCOHOL • GALLSTONE • TRAUMA • DUCTAL
OBSTRUCTION
• INFECTION • DRUGS • METABOLIC DISTURBANCES • ISCHEMIA • OTHER
Hepatitis C BACTERIAL Staphylococcus, E.Coli, Enterococcus, Enterobacteriae, Proteus, P.
Aeruginosa, Spyrocets, C. dyphteria, Legionella, Yersinia, Campylobacter, Salmonella, Mycobacteria, Mycoplasma FUNGAL Aspergillosis, Actyomycosis PARASYTES
ETIOLOGY • ALCOHOL • GALLSTONE • TRAUMA • DUCTAL
OBSTRUCTION
• INFECTION • DRUGS • METABOLIC DISTURBANCES
DRUGS ASSOCIATED WITH PANCREATITIS
ABSOLUTE RELATIONSHIP • AZOTHIOPRYNE • CHLOROTIAZIDE • ESTROGENS • FUROSEMIDE • SULFONAMIDES • TETRACYCLINE
• ISCHEMIA
• VELPROATE
• OTHER
• PENTHAMIDINE AND DDL
ETIOLOGY • ALCOHOL • GALLSTONE • TRAUMA • DUCTAL
OBSTRUCTION
• INFECTION • DRUGS • METABOLIC DISTURBANCES • ISCHEMIA • OTHER
DRUGS ASSOCIATED WıTH PANCREATITIS POSSIBLE RELATIONSHIP • • • •
L-ASPARAGYNASE CORTICOSTEROIDS ETACRYNIC ACID PHENPHORMINE
ETIOLOGY • ALCOHOL • GALLSTONE • TRAUMA • DUCTAL
OBSTRUCTION
• INFECTION • DRUGS • METABOLIC DISTURBANCES
THOUGHT TO BE RELATED WITH PANCREATITIS
• AMPHETAMINE • CHOLESTYRAMINE • PROPOXYPHENE • INDOMETASYNE • ISONIASYDE • MERCAPTOPURINE • OPIADS • RYFAMPISINE
• ISCHEMIA
• SALISILATES
• OTHER
• CIMETIDINE
ETIOLOGY • ALCOHOL • GALLSTONE • TRAUMA • DUCTAL
OBSTRUCTION
• INFECTION • DRUGS • METABOLIC DISTURBANCES • ISCHEMIA • OTHER
METABOLIC DISTURBANCES • HYPERLIPIDEMIA • HYPERCALCEMIA
ETIOLOGY • ALCOHOL • GALLSTONE • TRAUMA
ISCHEMIA • EMBOLIZATION OF PANCREATICODUODENAL ARTERY IN AORTOGRAPHY
• DUCTAL
OBSTRUCTION
• INFECTION • DRUGS • METABOLIC DISTURBANCES • ISCHEMIA • OTHER
• STENOSIS OF TRUNCUS COELIACUS • RUPTURE OF ANEURYSM OF AORTA ABDOMINALIS • MYOCARDIAL INFARCT
ETIOLOGY • ALCOHOL • GALLSTONE • TRAUMA • DUCTAL
OBSTRUCTION
• INFECTION • DRUGS • METABOLIC DISTURBANCES • ISCHEMIA • OTHER
OTHERS • OTOIMMUN DISEASES • PROTEIN ANOMALIES • SCORPION VENOM • PREGNANCY
CLINICALPRESENTATION • ABDOMINAL PAIN • NAUSEA-VOMITMENT • ANOREXIA • FEVER • ABDOMINAL MASS • ILEUS • JAUNDICE
PHYSICAL EXAMINATION • LOCALIZED/GENERALIZED ABDOMINAL TENDERNESS • ABDOMINAL DISTENTION • FEVER • TACHYCARDIA • HYPOTENSION • GREY-TURNER VE CULLEN SIGNS • CONFUSION, PSYCHOSE AND COMA
DIAGNOSIS BIOCHEMICAL MARKERS • • • • • •
SERUM AMYLASE AND ISOFORMES URINE AMYLASE AMYLASE-CREATININE CLEARANCE RATIO SERUM LIPASE AND ISOFORMES TRYPSINE PHOSPHOLIPASE-A
AMYLASE CONTAINING TISSUES • PANCREAS
P-ISOAMYLASE
• • • • • • • • •
S-ISOAMYLASE
SALIVARY GLANDS TUBA OVER ENDOMETRIUM PROSTATE BREAST LUNG LIVER SMALL BOWEL
DISEASES ASSOCIATED WITH HYPERAMYLASEMIA INTRAABDOMINAL CAUSES • PANCREATIC DISEASES ACUTE PANCREATITIS, CHRONIC PANCREATITIS, TRAUMA CARCINOMA, PSEUDOCYST, PANCREATIC ASCITES, ABCESS • NON-PANCREATIC DISEASES BILIARY DISEASES, BOWEL OBSTRUCTIONS, MESENTERIC INFARCT, PERFORATED PEPTIC ULCER,PERITONITIS, AFFERENT LOOP SYNDROME, ACUTE APPENDICITIS RUPTURE OF ECTOPICAL PREGNANCY, SALPENGITIS, RUPTURATED ANEURYSM OF AORTA
DISEASES ASSOCIATED WITH HYPERAMYLASEMIA EXTRAABDOMINAL CAUSES • DISEASES OF SALIVARY GLANDS, MUMPS, PAROTITIS, TRAUMA, PAROTIS STONES, RADIATION SIALADENITIS • AMYLASE CLEARANCE DEFECTS: RENAL FAILURE, MACROAMYLASEMIA
• OTHER: PNUEMONIA, PANCREATIC PLEURAL EFFUSION,
MEDIASTINAL PSEUDOCYST, CEREBRAL TRAUMA, SEVERE BURNS, DIABETIC KETOACIDOSIS, PREGNANCY, DRUGS
AMYLASE-CREATININE CLEARANCE RATIO =
URINE AMYLASE SERUM AMYLASE
X
SERUM CREATININE URINE CREATININE
X
100
OTHER LABORATORY EXAMINATIONS • • • • • • • •
WHOLE BLOOD COUNT SGOT, SGPT ALKALINE PHOSPHATASE BILIRUBINE BLOOD GLUCOSE BLOOD UREA AND CREATININE SERUM ELECTROLYTES DIAGNOSTIC PERITONEAL LAVAGE
IMAGING • • • • •
PLAIN X-RAY (THORAX AND ABDOMEN) ABDOMINAL ULTRASONOGRAPHY COMPUTERIZED TOMOGRAPHY MAGNETIC RESONANCE IMAGING ERCP
SCORING SYSTEMS IN ACUTE PANCREATITIS • RANSON CRITERIA • IMRIE CRITERIA • APACHE II (acute physiologic and chronic health enquiry) • MRCS (medical research council sepsis) • SAP (simplified acute physiologic)
RANSON CRITERIA
(GALLSTONE PANCREATITIS) ADMISSION • AGE >70 • LEUCOCYTE >18000/mm3 • BLOOD GLUCOSE >220mg/dl • SERUM LDH >400 IU/dl • AST >250 U/dl
IN THE FIRST 48 HOURS • DECREASED LEVEL OF HEMATOCRIT BY %10 • INCREASED LEVEL OF BUN >2mg/dl • DECREASED SERUM CALCIUM VALUE BELOW <8 mg/dl • BASE DEFICIT >5 mEq/L • ESTIMATED FLUID LOSS >4 L
RANSON CRITERIA
(NON-GALLSTONE PANCREATITIS) ADMISION • AGE >55 • LEUCOCYTE >16000/mm3 • BLOOD GLUCOSE >200mg/dl • SERUM LDH >350 IU/dl • AST >250 U/dl
IN THE FIRST48 HOURS • DECREASED LEVEL OF HEMATOCRIT BY %10 • INCREASED LEVEL OF BUN >5mg/dl • DECREASED SERUM
CALCIUM <8 mg/dl
• BASE DEFICIT >4 mEq/L • ESTIMATED FLUID LOSS >6 L • ARTERIAL PaO2 <60 torr
ASSESSMENT OF THE SEVERITY OF PANCREATITIS BIOCHEMICAL MARKERS • • • • • • • • • • •
NEUTROPHIL ELASTASE ACUTE PHASE PROTEINS TAP (tripsinogen activation peptide) PANCREATITIS RELATED PROTEIN (PAP) COMPLEMENT IL-6 TNF (tumor necrosis factor) RIBONUCLEASE ANTI-PROTEASES PHOSPHOLIPASE-A METHEMALBUMIN
ASSESSMENT OF THE SEVERITY OF PANCREATITIS RADIOLOGICAL EVALUATION • • • •
ULTRASONOGRAPHY CONTRAST ENHANCED CT ERCP ANGIOGRAPHY
COMPLICATIONS LOCAL COMPLICATIONS • BLEEDING • PSEUDOCYST • ABCESS • PHLEGMON • NECROSIS • PANCREATIC ASCITES
COMPLICATIONS SYSTEMIC COMPLICATIONS • RESPIRATORY FAILURE • CARDIOVASCULAR COMPLICATIONS • HEPATOBILIARY COMPLICATIONS • GASTROINTESTINAL COMPLICATIONS • RENAL FAILURE • MULTI-ORGAN FAILURE • METABOLIC DISTURBANCES • LESIONS OF SKIN AND BONE
TREATMENT • • • •
SUPPORTIVE TREATMENT SUPPRESSION OF EXOCRINE SECRETION OF PANCREAS INHIBITION OF PANCREATIC ENZYMES PROTECTION OF PANCREAS FROM FREE OXYGEN RADICALS • ELIMINATION OF TOXIC AGENTS IN PERITONEAL CAVITY
TREATMENT SUPPORTIVE TREATMENT • • • • • •
FLUID RESUSCITATION ELECTROLYTE REPLACEMENT ANALGESIA NUTRITIONAL SUPPORT ANTIBIOTICS RESPIRATORY SUPPORT
TREATMENT SUPPRESSION OF EXOCRINE SECRETION OF PANCREAS
• NASOGASTRIC SUCTION • H2 RECEPTOR ANTAGONISTS • ANTIACIDS • ANTICHOLINERGICS • GLUCAGON • CALCITONIN • SOMATOSTATIN
TREATMENT INHIBITION OF PANCREATIC ENZYMES • INHIBITORS OF PROTEASES • APROTININE • GABEXATE • CHAMOSTATE • FRESH FROZEN PLASMA • ANTIFIBRINOLITICS • CHLOROQUINE
TREATMENT PROTECTION OF PANCREAS FROM FREE OXYGEN RADICALS • CLEANSING AGENTS OF FREE OXYGEN RADICALS • XANTHINE OXYDASE INHIBITORS • ISOVOLEMIC HEMODILUTION
TREATMENT ELIMINATION OF TOXIC AGENTS • PERITONEAL DIALYSIS
Abdominal pain history physical examination serum enzyme levels Acute pancreatitis CRP, LDH, BT edematous pancreatitis
Necrotizing pancreatitis
daily follow-up until the symptoms disappear
ICU daily CRP, LDH
response +
response -
Ultrasonography Biliary pancreatitis Medical treatment
ERCP/papillotomy Elective biliary surgery
CT
(No complication, Focal necrosis -<%50)
Sepsis parameters
FNA - Culture
Surgery
TREATMENT SURGERY
•Necrosectomy in necrotizing pancreatitis •Cholecystectomy •ERCP •Surgery in complications (pseudocyst, ascites vs.)
TREATMENT SURGERY
NECROSECTOMY •Necrosis infected / sterile ? •Presence of sepsis
TREATMENT SURGERY NECROSECTOMY 3. Laparotomy • packing • closed lavage - drainage 2. CT-guided percutaneous necrosectomy
TREATMENT SURGERY
CHOLECYSTECTOMY Laparoscopic or open (during the same hospitalization period, if possible) Biliary drainage is best accomplished by ERCP
TREATMENT SURGERY
Treatment of pancreatic pseudocyst: 1.Conservative management 2.Percutaneous drainage (radiological) 3.Endoscopic (stenting vs.) 4.Surgical (cystogastrostomy or cystoduodenoostomy or cystojejunostomy) • Laparotomy • Laparoscopy
TREATMENT SURGERY
Pancreatic ascites 1. Endoscopic (pancreatic stent) 2. Surgical (drainage to jejunum,resection)
CHRONIC PANCREATITIS
DEFINITION Irreversible damage to the pancreas and the development of histologic evidence of inflammation and fibrosis and destruction of exocrine (acinar cell) and endocrine (islets of Langerhans) tissue
HISTOPATHOLOGY • Pancreas is normal at the initial period of the disease • As the disease progresses pancreas become wide and stiff • There are narrow and wide segments into the pancreatic ducts; the ducts become dilated and curled in time • Calcified stones may be present into the pancreatic ducts
ETIOLOGY • Alcohol • Pancreatic duct obstruction (trauma, acute pancreatitis, tumor etc.) • Hereditary pancreatitis • İnfantil malnütrisyon • İdyopatik
Classification of Chronic Pancreatitis •
Alcoholic
•
Tropical
Tropical calcific pancreatitis
Fibrocalculous pancreatic diabetes •
Genetic
Hereditary pancreatitis Cystic fibrosis Others? •
Metabolic
Hypercalcemia
Hypertriglyceridemia, acquired or inherited (e.g.,apoprotein C-II deficiency, lipoprotein lipase deficiency) Obstructive •
Benign pancreatic duct obstruction
Traumatic stricture
Stricture after necrotizing pancreatitis Stenosis of sphincter of Oddi
Pancreas divisum (with inadequate accessory papilla) Sphincter of Oddi dysfunction?
Malignant pancreatic duct stricture
Pancreatic, ampullary, or duodenal carcinoma •
Autoimmune
Isolated autoimmune chronic pancreatitis
Associated with autoimmune diseases (Sjögren’s syndrome, primary biliary cirrhosis, primary sclerosing cholangitis) •
Idiopathic
Early-onset Late-onset •
Asymptomatic pancreatic fibrosis
Chronic alcoholic patients Aged individuals
CLINICAL PRESENTATION • Abdominal pain • Nausea - vomiting • Weight loss • Infections • Steatorrhea • Diabetes
DIAGNOSIS • Laboratory: serum amylase and other laboratory examinations of pancreatic function – direct ve indirect) • Imaging: (Plain abdominal X-ray, CT, MRCP, ERCP) • Biopsy
TREATMENT • • • • • •
Cessation of alcohol Low fat diet Pancreatic enzyme supplements Morphine and tobacco should be avoided Analgesics Endoscopic interventions (sphincterotomy, stone removal, stent therapy vs.) • Surgery
TREATMENT surgery
Ampullary operations • Transduodenal sphincteroplasty • Septoplasty of pancreatic duct Denervation operations • Alcohol injection Drainage procedures • Puestow procedure Resection • Whipple procedure • Beger procedure • Total pancreatectomy
Complications • •
Pancreatic Pseudocyst Bleeding
• • •
Common Bile Duct Obstruction Duodenal Obstruction Pancreatic Fistula
• •
Cancer Dysmotility
Pseudocyst Wall, Pseudoaneurysms, Variceal Bleeding from Splenic Vein Thrombosis
External Pancreatic Fistula, Internal Pancreatic Fistulas